Zobrazeno 1 - 9
of 9
pro vyhledávání: '"ERCHENG CHEN"'
Autor:
Wei Wang, Yaozong Dong, Zhaoyang Wang, Yipeng Song, Rukun Zang, Dong You, Chengde Wang, Wei Jiang, Jinbo Ma, Ercheng Chen
Publikováno v:
Technology in Cancer Research & Treatment. 16:75-80
Background: To determine whether individualized radiation dose escalation after planned chemoradiation based on the decrease in tumor and normal tissue constraints can improve survival in patients with esophageal carcinoma. Methods: From August 2005
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2433bf6e2f1bc2dc6e30e36f66370e
https://doi.org/10.1177/1533034615627583
https://doi.org/10.1177/1533034615627583
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 13:e111-e116
Aim To evaluate the efficacy and safety of late-course hypofractionated radiation treatment of muscle-invasive bladder carcinoma after bladder-conserving surgery. Methods Seventy-six patients with transitional cell bladder carcinoma, stage II (T2-4N0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad137f2d3cc8a719c6b507ff594982a9
https://doi.org/10.1111/ajco.12351
https://doi.org/10.1111/ajco.12351
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 14:2477-2481
Aims and Background: The purpose of the research was to study the prognostic value of tumor 18F-FDG PET-based parameters in neoadjuvant chemoradiation for patients with squamous esophageal carcinoma. Methods: Sixty patients received chemoradiation th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c537627e4f10eb33c1a27c8ced29f68e
https://doi.org/10.7314/apjcp.2013.14.4.2477
https://doi.org/10.7314/apjcp.2013.14.4.2477
Both high expression of nucleophosmin/B23 and CRM1 predicts poorer prognosis in human gastric cancer
Publikováno v:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 124(12)
Nucleophosmin/B23 and CRM1 are molecular markers which play an important role in tumorigenesis and tumor progression in gastric cancer (GC). However, the association between the two remains unclear. This study evaluated the expression and the correla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6cf28b85f4ba5664a898cd2b41d1216
https://pubmed.ncbi.nlm.nih.gov/27714846
https://pubmed.ncbi.nlm.nih.gov/27714846
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 13:4163-4167
Aims: To prospectively assess the efficacy and safety of moderately hypofractionated conformal radiotherapy in patients with thoracic esophageal cancer. Methods and Materials: From Sept. 2002 to Oct. 2005, 150 eligible patients with T2-4N0-1M0 stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::527201e73ca0920c1a80f6f1647e1135
https://doi.org/10.7314/apjcp.2012.13.8.4163
https://doi.org/10.7314/apjcp.2012.13.8.4163
Publikováno v:
Technology in Cancer Research & Treatment. 10:25-30
Compared to conventional fractionated-dose radiotherapy, high hypofractionated-dose radiotherapy could yield tumoricidal effects. However, few clinical trials of hypofractionated radiotherapy in loco-regionally advanced incurable esophageal cancer at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcb64c75f0c46189e3df4b1004582631
https://doi.org/10.7785/tcrt.2012.500176
https://doi.org/10.7785/tcrt.2012.500176
Publikováno v:
Molecular and clinical oncology. 4(6)
Malignant pheochromocytoma is a rare tumor, for which there is currently no effective therapy. Cytoreductive surgery is recommended to reduce tumor burden and relieve the symptoms of catecholamine excess, although complete eradication of the lesions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33a43731c1ad815746531136e0946d28
https://pubmed.ncbi.nlm.nih.gov/27313863
https://pubmed.ncbi.nlm.nih.gov/27313863
Autor:
Yipeng Song, Yang Wang, Li Xu, Jinbo Ma, Ercheng Chen, Rukun Zang, Weihua Jia, Xiaofeng Tao, Likuan Hu
Publikováno v:
Carcinogenesis; May2015, Vol. 36 Issue 5, p538-542, 5p
Publikováno v:
Molecular & Clinical Oncology; Jun2016, Vol. 4 Issue 6, p1060-1062, 3p